Removal of Primary Tumor Improves Survival for Stage IV MBC
Comments
-
HLB, I can tell you how far I had to progress to have recognizable symptoms, with no tumor markers being checked. Far enough that my liver was so full of tumors I could not start with hormonal therapy but had to go straight to chemo. I'm unhappy that I had to lose my hair because of this, but then again I did get NEAD. Artistatheart, Taxol is an intravenous chemo; I had infusions three weeks on and one week off. Four to six cycles were planned. After three cycles the PET-CT showed NEAD. Taxol was a double-whammy to the cancer because it also punted me into menopause. We did two more cycles for good measure, then stopped before the developing neuropathy could cause permanent problems.
Regarding the alternative anesthesia, there is a member here called solfeo who describes how they used enough propofol to put her all the way out and then did a pectoral block, instead of the usual anesthesia, for her breast surgery. (Just do a search to find more.)
-
I had a PET, bone scan, and brain MRI prior to my mastectomy, as this was my doctor's standard of care. Brain MRI showed what they believed to be a cavernoma, not a met. Had surgery, no need for chemo or rads, and started on hormonals. Turns out that cavernoma was a brain met. It was removed during a craniotomy after I had a seizure. I firmly believe that my tumors being removed has contributed to my NED status. It just makes sense to me that the treatments can work better when they are only addressing any "free floaters" and not tumors.
-
Thank you for posting this report. I was dx in May 2015 at first they said stage 2 Scheduled me for mastectomy . I insisted on a pet scan . PS they found 2 bone mets. Surgery off the table. First oncologist said no one will do a mastectomy on stage 4 only a butcher I asked about radiation, cyber knife he just laughed he was horrible no bedside manner he actually asked me how old do you think you will live to and being a very optimistic person I said given a choice in my 80's and he just laughed and said wont happen. I was placed on Femara and Ibrance and after one month the breast tumor which I could feel started shrinking and when I convinced him to do a pet scan at 3 months everything was shrinking fast. At that point I had done my research found new doctors and had CyberKnife to the 2 bone mets and bilateral mastectomy 7 weeks ago clear margins and negative nodes had a pet scan last week and a present its clear NED ! The two bone mets that were cyber knifed are dead . I pray that this remains but I felt that I was healthy to have the surgery and by the time the results from all these trials on mastectomy for newly dx stage 4 with limited bone mets came out it could take years and years. Thank you again for posting this !
-
Wow!
I was surprised to read this critique of the study (reported in http://meetinglibrary.asco.org/content/170268-176).
It's always fascinating to me that there's a gap between what we surmise from our individual circumstances and what the data shows for larger groups of study participants. Individuals vs. statistics. Anecdotal evidence (stories) vs. data.
healing regards, Stephanie
Release oversells evidence when claiming new standard of care for advanced breast cancer
University of Pittsburgh University of Pittsburgh Schools of the Health Sciences
International trial changing standard of care for advanced breast cancer
Our Review Summary
A study presented at the American Society of Clinical Oncology (ASCO) scientific conference that supposedly will "change the standard of care" for patients with advanced breast cancer should have more evidence backing up the claim. This news release gives short shrift to salient details, including costs, risks, the quality of the evidence, and proof of the novelty of this surgery-first approach.
The release doesn't acknowledge that the study found no difference between groups for the primary outcome (survival at 36 months). A statistical difference was found when the study was extended to 40 months but on a smaller subset of the original full sample group. The release makes the results sound like a success by focusing on subgroups of patients, but those results should be interpreted very carefully.
Why This Matters
Although the news release was able to discuss in simple terms some of the results of the study, there is concern when broad statements such as claims of a change in practice will occur based on the results of one study.
There were also some study limitations that were not addressed in the news release. The original study was powered to detect differences in survival between the two groups at 36 months, but the study failed to find a difference. It was only with subgroup analyses and a longer follow-up time did the researchers find significant differences between the groups. The concern is that the study may not have been adequately powered for these subgroup analyses and therefore, the results may not be accurate.
Much more critique to read at:
-
My oncologist was more supportive of the idea of surgery than my BS, but he got her on board with the idea and I had a unilateral MX last month. It just makes logical sense to me that reducing the burden of disease will be easier on my body and perhaps I can get my immune system strong enough to help fight off cancer cells too.
-
Thanks, longtermsurvivor, for that critical article on this latest study. I've been feeling angry, betrayed and confused ever since the new study came out. It helps to realize that there is no guarantee that the treatment I got would give me more time (or less time) than the treatment I didn't get. But it has been hard, reading about how, if I had gotten the surgery in the beginning, I might have had an extra nine months. (There is no way I can go through that kind of surgery now, due to my life circumstances. But it would have been very possible 20 months ago, when I was first diagnosed and staged.)
-
Hi everyone,
Although I've posted a couple of critiques and background information on this study, I believe that each of us must make personal decisions about what we can and can't abide in medical interventions.
It's stressful to live with active, visible cancer.
I know as I've had tumors on my unreconstructed chest wall for over 25 years now.
In the early years, we tried surgically removing them, but more always popped up. So next came radiation to a very wide field. It didn't get rid of all the tumors and those left began growing again within weeks. I tried a variety of topical treatments, including more surgery and alternative approaches. Zip. And some chemotherapy that beat me down, not the cancer. The surgery and radiation damaged my chest wall and nerves. I live with the long term effects of medical treatments.
Now, I just live with those tumors and other cancer in my body.
But it is stressful and I've engaged a wide range of mind-body practices to live peacefully and well with the metastatic disease that's now in many regions of my body. These practices have also helped me to live well while dying.
To be clear, I don't expect anyone else to live like this. My doctors and I didn't think I had many options, so I needed to accept and adapt. Still do.
For many, mastectomy or surgical removal of evident disease is a sensible choice. We aren't just medical/material beings, but multi-faceted human beings with different stress tolerance.
So, I say study the studies and statistics, but recognize that you are an "n of one" as they say. You are an individual not a statistic and you must go for the choices that make sense to you...sometimes against the best medical advice.
healing regards, Stephanie
-
Could anyone tell me where to find that study? The link was dead/changed on the eurekalert.org post. I had an appointment with my oncologist today and I mentioned what I called the "University of Pittsburgh" study and he didn't know what I was talking about. I also called my breast surgeon and she didn't know what I was talking about.
This is a HUGE deal for me because I am exactly the situation described in the article. Diagnosed at stage 4 almost from the beginning, and all the docs and surgeons (they brought my case to a special board) said that I shouldn't have surgery. My primary tumor is large and bothersome, although not particularly painful and doesn't protrude out of the skin. The board said that "all the research" says I shouldn't have "unnecessary surgery" and a lumpectomy to get rid of my primary tumor would be unnecessary. I felt right away that removing the primary tumor would be beneficial to my health. If not my physical health (as the docs told me time and time again) then at least my mental health.
I now want to schedule my lumpectomy with this article as backup. Yet they don't know what I'm talking about! Is it a valid study? Why haven't the docseven heard of it???!
Thanks!
-
Hi Mamalala,
The Eurekalert link worked for me, so I've just copied and pasted the entire press release below.
Maybe your doctors don't know of the study, because it was mainly funded and done in Turkey? Maybe they're calling it "The Turkish Study"? Or because it's so small, just 274 participants? Or that the statistical findings really don't change the standard of care? Or that it's newly released?
Just a few thoughts. Be sure to read the critique I posted on June 9 and my own thoughts on June 10.
Definitely good for your mental health to have it removed. Worry and fear are psychic pain and you deserve relief from that, just as you do from physical pain!
Mamalala, you may need to argue to get what you want and need. I hope you will persist and prevail!
Warmest of healing regards, Stephanie
xxx
PUBLIC RELEASE: 2-JUN-2016
International trial changing standard of care for advanced breast cancer
UNIVERSITY OF PITTSBURGH SCHOOLS OF THE HEALTH SCIENCES
PITTSBURGH, June 2, 2016 - Surgery to remove the primary tumor in women diagnosed with stage IV breast cancer, followed by the standard combination of therapies, adds months to the patients' lives, compared with standard therapy alone, an international clinical trial led by a University of Pittsburgh Cancer Institute (UPCI) professor revealed.
The results of the phase III randomized, controlled trial will be presented Saturday at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. The study was selected for the society's "Best of ASCO," an effort to condense the research "most relevant and significant to oncology" into a two-day program to increase global access to cutting-edge science.
"Our findings will change the standard of care for women newly diagnosed with stage IV breast cancer," said principal investigator Atilla Soran, M.D., M.P.H., clinical professor of surgery, University of Pittsburgh School of Medicine, and breast surgical oncologist with UPMC CancerCenter. "We've shown that surgery to remove the primary tumor--either through lumpectomy or mastectomy--followed by standard therapy, is beneficial over no surgery."
Dr. Soran began the trial in 2007, ultimately recruiting a total of 274 women newly diagnosed with stage IV breast cancer from 25 institutions. Half the women received standard therapy, which avoids surgery and consists of a combination of chemotherapy, hormonal therapy and targeted therapy, while the other half first had surgery to remove their primary breast tumor, followed by the standard therapy.
At about 40 months after diagnosis, the women who received the surgery plus standard therapy lived an average of nine months longer than their counterparts who received standard therapy alone. Nearly 42 percent of the women who received surgery lived to five years after diagnosis, compared with less than 25 percent of the women who did not receive surgery.
The trial also showed that surgery in younger women with less aggressive cancers resulted in longer average survival than in women with more aggressive cancers that had spread to the liver or lungs.
"Our thinking is similar to how you might approach a battle against two enemies," said Dr. Soran. "First you quickly dispatch one army--the primary tumor--leaving you to concentrate all your efforts on battling the second army--any remaining cancer."
###
This research was primarily funded by the Turkish Federation of Societies for Breast Diseases. The study received scientific advisement from UPMC and assistance with statistical analysis from epidemiologists at the University of Pittsburgh Graduate School of Public Health.
About UPCI
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
-
Upon my State IV diagnosis I was also told by my Onc that I could not have a masectomy, just T/H/P chemo. After my six rounds, PET scan showed NED. My Onc said the tumor board at the hospital reviewed my case and said because of the complete metabolic response to chemo, they were approving my masectomy. My Onc said that by removing the primary tumor it may help with progression. Had masectomy last July and had CT scan yesterday and it showed continued NED status.
-
I was diagnosed de novo with mets to liver and possible met to bone in January 2016. Surgery is on the table, but only after we see if we can get the tumors smaller with targeted therapy. Neoadjuvent therapy is the standard of care in many cases now, even when surgery is definitely part of the treatment plan. Neoadjuvent therapy means shrinking the tumor with chemo/hormonal treatment before surgery. There are solid studies that show improved outcomes in certain cases with neoadjuvent therapy.
My oncs have told me that they will definitely be considering surgery if I get rid of the mets with the current treatment, but it is just an option. We'll weigh the risks and the benefits when we get there. As we know, with stage IV we're all flying by the seat of our pants.
This study is interesting and I am so glad it was shared, but one study means nothing. I've seen studies that suggests that if you don't get everything out with surgery, removing the primary tumor provokes growth of the metastasis. It's like the satellites feel the loss of the primary tumor and it provokes their growth.
It takes just a small colony of a certain type of cancer cells (cancer stem cells) to initiate metastasis. There are so many cancer cells in my body. it doesn't seem like something I can fight by removing one or two visible tumors in my breast. My sense is that I need fight the metastasis systemically.
Aggressive measures like surgery weaken my body, increase stress and disrupt my anti-cancer regime (diet, exercise).
There are better, more gentle, system-wide treatments in the pipeline that may be more effective to suppress metastasis. My primary strategy is to keep myself strong, healthy and whole until they figure something out. We're in a time when several new treatment options are appearing every year. so that is something to consider as you weigh surgery.
From what I have learned I am considering surgery, but no sold on it. We'll see how I am doing after a two or three more scans. I don't see this one study as conclusive.
>Z<
-
Mamalala if you cannot get your docs to agree, I would go for another opinion, and even a 3rd or 4th to get what you want. The fact that the tunor is large is weighing on you and you deserve to have it out if that's what you need for relief. I also agree with the idea of shrinking it with treatment and then getting surgery. There are many things to do to make sure you heal quickly and bring your immunity back up. I didn't find lumpectomy to be a big deal. I remember reading somewhere that some treatments do not kill the stem cells, which is another plus for getting the tumor out.
-
Maybe soon we will discover improved outcomes, even and especially in Stage IV cases, with perhaps a three-step initial treatment: 1. neoadjuvent therapy to shrink the primary tumor(s), 2. Ketoraloc/torodol before surgery for recurrence prevention, and 3. surgery to eliminate the primary tumor(s) burden.
Patients then receive continued care (chemotherapy and/or radiation), depending upon their situation.
I hope that all can achieve NED status for so long that the medical community begins to consider "remission" and "cure" as attainable in our lifetime.
Remember that AIDS was once considered a death sentence and now, if treated early with new protocols, it is considered chronic, with some patients now in remission or close to it. I know that's a lot of qualifiers, but progress.
Wishing everyone all the best,
Mominator
-
I had my primary tumor removed about a year after diagnosis and all other mets have remained stable every since. I had been on 3 different chemo meds prior to having my right breast removed. It's seems none of the chemo meds were able to control the primary tumor in the breast therefore my oncologist suggested the mastectomy. I have now been off kadcyla since November 2015 and currently receiving herceptin ever 21days. I was also able to begin reconstructive surgery in December 2015. I truly believe removing the primary tumor improved things for me.
ChicagoGirl
-
I was diagnosed StIV right out of the gate. IDC, grade 3 went from the size of a grape when I found it to the size of a large lemon 3 weeks later at my yearly exam to the size of a grapefruit ten days later when I started chemo. I did A/C, then taxol, and fought for and got a double mastectomy, followed by radiation (during which I was on Xeloda). Then Ibrance/Femera (plus x-geva and zometa). I also use marijuana both medicinally and recreationally (hey, a gal's gotta have some fun). I've had three scans and all have shown me to be NED. I told my Dr. the day she told me it was stage 4 that my plan was to go balls to the wall, and that is just what we've done. This study makes me so happy--I sent a copy to my surgeon, who tried to talk me into not doing a mastectomy.
-
I was Stage IV de novo only because they stumbled upon the mets. They sent me for an MRI for my other breast (which they don't always do). An abnormality on my sternum was reported by the radiologist. I was sent for bone scan and found mets in my sternum, rib, spine, hips and pelvis (a bone biopsy confirmed the cancer). I also had ct scans for chest, pelvis and abdomen. Only bone mets found. So before finding the mets I was going to have neoadjunctive chemo to shrink the tumor so that I could have a lumpectomy. But after finding the mets I was told surgery was not the standard of care for Stage IV. My BS handed me off to the MO. However, although they advised against it, I was told that if I wanted the mastectomy (or lumpectomy) I could have it. They understood the mental and emotional side and that if I really wanted it out they would do it. But their position was that there was no evidence that removing the primary tumor would benefit a patient. It didn't extend longevity. The cancer was already in my system and needed to be treated systemically and that hormonal therapy was very successful in preventing progression. Since we are all shell shocked when we are first diagnosed with stage iv from the get go it is difficult to research and weigh all the options and come to a decision on how to proceed quickly. You feel like you need do something as soon as possible. I went for a second opinion at Dana Farber and they agreed with the diagnosis and treatment plan from MGH. Hence I didn't have surgery and went straight to hormonal therapy (Tamoxifen) and zometa. I have had several meetings with my MO and BS since then because my breast tumor was painful at times and since it has shrunk I could have a lumpectomy at this point. The most recent meeting came at a time that I was changing treatment from Tamoxifen to Ibrance/Letrozole due to small progression in my spine. They wanted me to wait a few months to see how I responded to the new protocol. My MGH team and the doctor and Dana Farber have said that having the primary tumor helps evaluate my response to treatment. We can feel if it softens and shrinks or if it begins to harden and grow. It had started to harden right around the time of progression in my spine was found. Since being on Ibrance/letrozole it has softened quite a bit and shrunk. I met with my BS a couple of months ago and we decided to hold off on surgery because my response to treatment was so good. I have been on this see saw ever since diagnosis. I have read studies that say it's better to remove the tumor and others that say it is best not to. It has just always felt like a stalemate. I am straddling both sides of the argument with no compelling fact to push me one way or the other. For now I stay the course I am on. Fortunately I still have the option for surgery on the table if I want it. Sigh....
-
I realize this is an old-ish thread, but found it relevant to my situation and thought others might as well. I was just diagnosed stage IV de novo, 2 small mets to the liver, E/P-, HER2+. My tumor load is low, and after one treatment cycle (TCHP), I actually can no longer feel the tumor I originally found in my breast and the nodes are shrinking as well. My surgeon is recommending a double mastectomy and radiation as soon as I finish my 6 cycles of TCHP, while my oncologist wants to wait and see what the cancer does first and thinks I should complete the year of pertuzumab/herceptin before surgery is on the table. I'm going to get a second opinion at MD Anderson (with both my oncologist's and surgeon's blessing). I'm BRCA1+, so I know that factors into the equation as well.With so much conflicting information out there, it's a tough call.
-
Mommyerin - hopefully others will chime in, since this is an old thread. I haven't seen any new research on this lately in my constant search.
I am interested in what your second opinion says as I am also in a similar situation. My onc and surgeon are good with my double mastectomy after 6 rounds of TCHP, but I'm curious if I should wait. They are also open to exploring local therapy for my liver if mets remain, since they are few.
Update if you can and wishing you the best of luck!
-
livebig- I will definitely let you know! I'm personally leaning towards the mastectomy sooner rather than later because of my BRCA1+ mutation, which increases the likelihood that I'll develop new breast cancer disease at some point. No thank you! One type of breast cancer is more than enough. So, they need to go, but the question is when. Please keep me posted on how they approach your liver mets. Stay in touch and best of luck to you as well
-
MommyErin - also interested. looking forward to your report.
>Z<
-
I was not stage iv de novo, rather stage 1 then metastatic. But I had a breast tumor at the same time as the liver mets, and my onc thinks the breast tumor was metastatic disease. Like AnimalCracker's onc, my onc used the easily felt breast tumor to monitor my response to treatment. The breast tumor disappeared on taxol, and has not been seen or felt since -- not on exam, PET/CT, breast MRI, or ultrasound -- even though the liver tumors remained (visible but smaller and dormant for a while and then recently active again). Just thought I would throw that out there because it supports the idea of giving systemic treatment a chance in some cases. Of course the decision has to be very individualized.
-
I emailed the author of the Pittsburg study about a month ago to ask about more details regarding the conclusion that "primary tumor removal may improve prognosis". In his data set, the people with liver and lung mets did not have improved survival time after the removal of primary tumor (mastectomy or lumpectomy), so that discouraged me from pursuing breast surgery at this time. His study also used surgery followed by systemic therapy, rather than systemic therapy followed by surgery, so the surgeon I consulted felt that if you have a good response to ST, there is no evidence of additional benefit for breast surgery. Soran (the author of this RCT) concurred with my surgeon on this one.
That said, I don't have a BRCA mutation, though I'm in the process of repeating my genetic tests with a different testing service. The results of that test will inform my thinking, as will whatever is going on in my breast/lymph nodes.
-
MommyErin, we are almost in the exact same situation. I was diagnosed March 13th, found possible liver mets from MRI and CT on March 29th. Starting TCHP this coming Thursday, 4/6. I have a liver biopsy Tuesday to confirm the liver mets. Not sure if surgery is still on the table or not, but I do want a second opinion at MD Anderson. How did you start that process and find someone to see there? Thanks!
-
LisaY- Thank you for all that information! Very helpful.
Epicats- So sorry you're joining the club. Feel free to message me if you want to talk more in depth about all this. I'll be thinking about you Thursday and hoping your first treatment goes well. Regarding MD Anderson, it sounds like they get a lot of referrals so getting an appointment was a pretty straightforward process. Just call. They'll need to verify your insurance before they'll schedule you though. The initial phone interview took a good 15 minutes or so. They ask a lot of questions about your diagnosis, tests you've had done, treatments, etc.
-
Divine.. thank you for guiding me to this thread! I was diagnosed de novo in March 2015 (ER/PR+, HER2-, mets in my T3, tumors in breast). No surgery (except oopherectomy- I'm sure I spelled that wrong), no chemo (besides letrozole and Ibrance),no radiation... Last week at my oncologist appointment, he said that since I have oligometastatic disease (just in one very faint spot in my spine), I could have the option of having a lumpectomy (if they can even find the 3 tumors - thank you letrozole/Ibrance for shrinking) or double mastectomy plus radiation or gamma knife to my spine. I had found one research paper on this and had given it to him a year ago. He obviously never forgot it. He always said "but that was only one study". Now he's saying that maybe I was ahead of the curve and that is how treatment might go for those ogliometastatic disease. I wanted to get rid of the "mother ship" from the beginning and now he's saying it's a possibility. I DON'T KNOW WHAT TO DO! So much going through my head.... thank you for all the information on this thread! I'm going to be reading thoroughly!
-
Alice, your treatment interests me, as I had a very similar dx, and a very different treatment plan. Of course, Ibrance was not yet available in 2011, here is my two sided take away. I was ER/PR +, HER -, with two palpable breast tumors and one bone met in my hip. I had the works..chemo, surgery, radiation. If We had today's options I am not sure we would have been as aggressive. I wish I still had my breast, and I wish I had not radiated my chest. The collateral damages were not small.
On the flip side, I was NED for 3.5 years before I had some bone progression. Those 3.5 years of feeling like I didn't have cancer, feeling normal, were priceless. In addition I did get over a year of inactivity on Ibrance, but I was alwYs and constantly aware of those little buggers in my body. Now I may have Activity in my liver.
I think my point is that doing all of the aggressive stuff is not a guarantee either. I think it's a coin flip, and a personal decision. I'm not sure if there is a right or wrong yet. I do envy you for having the choice.
Btw, I'm still considered oligo, according to my ONC. That may change after my liver biopsy. We'll see. Almost six years with minimal disease has been good. There are women on here with even more years than that. I wish you the best.
Stefanie
-
Stefanie, with such minimal disease, I wonder if local treatment of the liver met would be considered for you.
-
Stefanie - Seconding Shetlands observation.
>Z<
-
Depending on the F1 results, he wants the tumor In place so he can see the treatment working(or not). I don't totally disagree, but if the treatment doesn't get rid of it completely, I would ask for it to be locally treated. Still waiting for the call from sceduling.
-
That sounds reasonable. Because with systemic treatment you are treating any little unseen mets, too. If the liver tumor disappears with either drug treatment or some kind of zapping (very technical term), that would get you back to bone only, in a sense.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team